![Larry A. Sklar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Larry A. Sklar
Corporate Officer/Principal bij The University of New Mexico
Profiel
Larry A.
Sklar is the founder of Essen Instruments, Inc. founded in 2006.
He is currently the Director-Basic Research at The University of New Mexico.
Dr. Sklar holds a doctorate degree from Stanford University.
Actieve functies van Larry A. Sklar
Bedrijven | Functie | Begin |
---|---|---|
The University of New Mexico | Corporate Officer/Principal | - |
Eerdere bekende functies van Larry A. Sklar
Bedrijven | Functie | Einde |
---|---|---|
Essen Instruments, Inc.
![]() Essen Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI. | Oprichter | - |
Opleiding van Larry A. Sklar
Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Essen Instruments, Inc.
![]() Essen Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI. | Electronic Technology |